Diane Borska

Find me on:

Recent Posts

Not Your Grandfather’s Gas Station:  Shell explores new technologies and business models at its gas station network in Europe

Posted by Diane Borska on Oct 26, 2017 2:47:27 PM

About a month ago, I was at a conference held in the motor city, also known as Detroit.  The conference topic was electrification and mobility with the discussion centered not on “if” the transportation sector was moving toward electrification but “when,” specifically, “how quickly.”

Read More

Topics: Energy and Utilities, strategic planning

Qualitative Methods Enrich Quantitative Data

Posted by Diane Borska on Oct 27, 2016 9:22:14 AM

Co-Written by Ola Jachtorowicz

Seventy-six percent of millennials want to drive an eco-friendly car. Ninety-two percent of students prefer physical books to e-readers. Ninety percent of senior executives confirm that customer experience is one of their top three priorities. Sixty-seven percent of U.S. manufacturing executives plan to increase investments in data analytics next year.

Data is king. Statistics and opinion polls accompany every article, analysis, and prediction. It’s difficult to find a claim without a piece of quantitative evidence behind it.

Read More

Topics: Competitive Intelligence, Fuld + Company, Competitive Strategy

The Risks and Drama of Merger Mania - Can We Learn from Experience?

Posted by Diane Borska on Jul 13, 2015 10:00:00 AM

UPDATE: Robust analytical methodologies can provide executives with insight regarding industry trends. This blog, previously produced by Diane Borska, Global Principal at Fuld + Company, on mergers and acquisitions is a demonstration of the power of strong industry understanding and well-executed analysis

Nearly 18 months after the Aetna – Humana deal was first announced, a federal judge has ruled the transaction would violate antitrust laws. As a result, it is all but certain that the deal will not go forward and analysts believe the closure of the other significant industry transaction involving Anthem and Cigna, is also in jeopardy. Observing the parallels of merger activity in another industry with relevant characteristics to health insurers, allowed us to recognize early on the risks these transactions would face and conclude that the pace of industry consolidation may be slow and face considerable challenges.

Read More

Topics: Competitive Intelligence, Events, Brand Insights, Market Analysis, Pharma, Healthcare, Industry Convergence, Life Sciences, Merger and Acquisition

Fuld + Company Blog

The material on this page draws on the research and experience of Fuld + Company thought leaders, consultants and others. Learn more about our expertise here.

Recent Posts

Request for Information

If you'd like someone at Fuld to contact you regarding your strategic competitive challenges, fill out the form below.